Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04522908
Title Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Compensated Liver Cirrhosis
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications

hepatocellular carcinoma

Therapies

Cabozantinib

Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.